These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 26951135

  • 21. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
    Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB.
    J Am Soc Hypertens; 2016 Oct; 10(10):755-762. PubMed ID: 27614923
    [Abstract] [Full Text] [Related]

  • 22. Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review.
    Hoxhaj P, Shah S, Muyolema Arce VE, Khan W, Sadeghzadegan A, Singh S, Collado GF, Goyal A, Khawaja I, Botlaguduru D, Razzaq W, Abdin ZU, Gupta I.
    Cureus; 2023 May; 15(5):e38907. PubMed ID: 37303338
    [Abstract] [Full Text] [Related]

  • 23. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.
    Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H.
    Neurology; 2018 Oct 16; 91(16):e1539-e1544. PubMed ID: 30232253
    [Abstract] [Full Text] [Related]

  • 24. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F, Karabin B, Mehdirad A.
    Clin Auton Res; 2017 Jul 16; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract] [Full Text] [Related]

  • 25. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.
    Clin Auton Res; 2001 Aug 16; 11(4):235-42. PubMed ID: 11710796
    [Abstract] [Full Text] [Related]

  • 26. Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Goodman BP, Claassen D, Mehdirad A.
    Clin Auton Res; 2017 Jul 16; 27(Suppl 1):17-19. PubMed ID: 28631223
    [No Abstract] [Full Text] [Related]

  • 27. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH, Kinter CW, Wight J, Neelam AR, Krakow D.
    J Med Case Rep; 2020 Jun 20; 14(1):73. PubMed ID: 32560740
    [Abstract] [Full Text] [Related]

  • 28. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
    Kaufmann H.
    Clin Auton Res; 2008 Mar 20; 18 Suppl 1():19-24. PubMed ID: 18368303
    [Abstract] [Full Text] [Related]

  • 29. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015 Mar 20; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 30. Droxidopa for Symptomatic Neurogenic Hypotension.
    Ferguson-Myrthil N.
    Cardiol Rev; 2017 Mar 20; 25(5):241-246. PubMed ID: 28604565
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial.
    Kaufmann H, Vickery R, Wang W, Kanodia J, Shibao CA, Norcliffe-Kaufmann L, Haumann B, Biaggioni I.
    Clin Auton Res; 2021 Dec 20; 31(6):699-711. PubMed ID: 34657222
    [Abstract] [Full Text] [Related]

  • 32. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D, Lew M, Claassen D, Goodman BP.
    Clin Auton Res; 2017 Jul 20; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract] [Full Text] [Related]

  • 33. Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.
    McDonell KE, Preheim BA, Diedrich A, Muldowney JAS, Peltier AC, Robertson D, Biaggioni I, Shibao CA.
    J Clin Hypertens (Greenwich); 2019 Sep 20; 21(9):1308-1314. PubMed ID: 31368635
    [Abstract] [Full Text] [Related]

  • 34. Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.
    Hauser RA, Favit A, Hewitt LA, Lindsten A, Gorny S, Kymes S, Isaacson SH.
    Neurol Ther; 2022 Mar 20; 11(1):459-469. PubMed ID: 35107750
    [Abstract] [Full Text] [Related]

  • 35. Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.
    Mehdirad A, Karabin B, Gupta F.
    Clin Auton Res; 2017 Jul 20; 27(Suppl 1):25-27. PubMed ID: 28634637
    [No Abstract] [Full Text] [Related]

  • 36. Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease.
    McCullough PA.
    Cardiol Ther; 2019 Jun 20; 8(1):145-150. PubMed ID: 30627953
    [Abstract] [Full Text] [Related]

  • 37. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I.
    Curr Cardiol Rep; 2014 Nov 20; 16(11):542. PubMed ID: 25303896
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.
    Patrick K, Martin T.
    JBI Database System Rev Implement Rep; 2017 Sep 20; 15(9):2287-2294. PubMed ID: 28902695
    [Abstract] [Full Text] [Related]

  • 39. Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.
    Marsili L, Duque KR, Sturchio A, Sobrero G, Premoli I, Dwivedi AK, Espay AJ, Merola A.
    Parkinsonism Relat Disord; 2022 Jun 20; 99():62-64. PubMed ID: 35605513
    [Abstract] [Full Text] [Related]

  • 40. Neurogenic Orthostatic Hypotension: An Underrecognized Complication of Parkinson Disease.
    Sin MK, Khemani P.
    J Neurosci Nurs; 2020 Oct 20; 52(5):230-233. PubMed ID: 32649380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.